Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Inhaled BIBN 4096 BS in Healthy Volunteers
NCT02194777Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2001
- Primary completion
- Aug 2001
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in migraine comparing BIBN 4096 BS with Placebo (2 arms). Primary endpoints: Number of patients with adverse events up to 24 days, Change in lung function measurement specific conductance and 6 more. Started Jun 2001; status: completed.
02
Drugs
olcegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02194777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194777.